Healthcare Triangle, Inc. (HCTI) stock
HCTINasdaqServices-Computer Integrated Systems DesignFiscal year ends December 31
$3.38+0.05 (+1.50%)
Close on Nov 17, 2026Market cap $6.85MP/E –Yield –
Healthcare Triangle r&d expenses
Research and development expenses are spending on new products and technology.
Healthcare Triangle's R&D Expenses for the twelve months ending Jun 30, 2026 was $474.00K. For fiscal 2025 it was $536.00K, up 24.9% from the year before. The highest annual figure on record is $8.14M in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $536.00K | +24.9% |
| FY2024 | Dec 31, 2024 | $429.00K | -46.3% |
| FY2023 | Dec 31, 2023 | $799.00K | -90.2% |
| FY2022 | Dec 31, 2022 | $8.14M | +54.8% |
| FY2021 | Dec 31, 2021 | $5.26M | +201.6% |
| FY2020 | Dec 31, 2020 | $1.74M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $51.00K | -7.3% |
| Q1 FY2026 | Mar 31, 2026 | $85.00K | -41.0% |
| Q4 FY2025 | Dec 31, 2025 | $279.00K | +59.4% |
| Q3 FY2025 | Sep 30, 2025 | $59.00K | -71.5% |
| Q2 FY2025 | Jun 30, 2025 | $55.00K | -56.7% |
| Q1 FY2025 | Mar 31, 2025 | $144.00K | +38.5% |
| Q3 FY2024 | Sep 30, 2024 | $175.00K | +224.1% |
| Q2 FY2024 | Jun 30, 2024 | $207.00K | +102.9% |
| Q1 FY2024 | Mar 31, 2024 | $127.00K | -76.4% |
| Q4 FY2023 | Dec 31, 2023 | $104.00K | -97.9% |
| Q3 FY2023 | Sep 30, 2023 | $54.00K | -96.3% |
| Q2 FY2023 | Jun 30, 2023 | $102.00K | -84.2% |
| Q1 FY2023 | Mar 31, 2023 | $539.00K | -49.4% |
| Q4 FY2022 | Dec 31, 2022 | $4.96M | +234.3% |
| Q3 FY2022 | Sep 30, 2022 | $1.47M | -33.3% |
| Q2 FY2022 | Jun 30, 2022 | $646.00K | -20.5% |
| Q1 FY2022 | Mar 31, 2022 | $1.07M | +40.8% |
| Q4 FY2021 | Dec 31, 2021 | $1.48M | +441.5% |
| Q3 FY2021 | Sep 30, 2021 | $2.20M | +300.6% |
| Q2 FY2021 | Jun 30, 2021 | $813.00K | – |
| Q1 FY2021 | Mar 31, 2021 | $757.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $273.66K | – |
| Q3 FY2020 | Sep 30, 2020 | $550.17K | – |
See a number that looks wrong?